Optimization of a 3D dynamic culturing system for in vitro modeling of Frontotemporal Neurodegeneration-relevant pathologic features

Frontotemporal lobar degeneration (FTLD) is a severe neurodegenerative disorder that is diagnosed with increasing frequency in clinical setting. Currently, no therapy is available and in addition the molecular basis of the disease are far from being elucidated. Consequently, it is of pivotal importance to develop reliable and cost-effective in vitro models for basic research purposes and drug screening. To this respect, recent results in the field of Alzheimer’s disease have suggested that a tridimensional (3D) environment is an added value to better model key pathologic features of the disease. Here, we have tried to add complexity to the 3D cell culturing concept by using a microfluidic bioreactor, where cells are cultured under a continuous flow of medium, thus mimicking the interstitial fluid movement that actually perfuses the body tissues, including the brain. We have implemented this model using a neuronal-like cell line (SH-SY5Y), a widely exploited cell model for neurodegenerative disorders that shows some basic features relevant for FTLD modeling, such as the release of the FTLD-related protein progranulin (PRGN) in specific vesicles (exosomes). We have efficiently seeded the cells on 3D scaffolds, optimized a disease-relevant oxidative stress experiment (by targeting mitochondrial function that is one of the possible FTLD-involved pathological mechanisms) and evaluated cell metabolic activity in dynamic culture in comparison to static conditions, finding that SH-SY5Y cells cultured in 3D scaffold are susceptible to the oxidative damage triggered by a mitochondrial-targeting toxin (6-OHDA) and that the same cells cultured in dynamic conditions kept their basic capacity to secrete PRGN in exosomes once recovered from the bioreactor and plated in standard 2D conditions. We think that a further improvement of our microfluidic system may help in providing a full device where assessing basic FTLD-related features (including PRGN dynamic secretion) that may be useful for monitoring disease progression over time or evaluating therapeutic interventions

Exploring Alzheimer's disease mouse brain through X-ray phase contrast tomography: From the cell to the organ

Alzheimer's disease (AD), the most common form of dementia, is a progressive neurodegenerative disorder associated with aberrant production of beta-amyloid (A beta) peptide depositing in brain as amyloid plaques. While animal models allow investigation of disease progression and therapeutic efficacy, technology to fully dissect the pathological mechanisms of this complex disease at cellular and vascular levels is lacking.X-ray phase contrast tomography (XPCT) is an advanced non-destructive 3D multi-scale direct imaging from the cell through to the whole brain, with exceptional spatial and contrast resolution. We exploit XPCT to simultaneously analyse disease-relevant vascular and neuronal networks in AD mouse brain, without sectioning and staining. The findings clearly show the different typologies and internal structures of A beta plaques, together with their interaction with patho/physiological cellular and neuro-vascular microenvironment. XPCT enables for the first time a detailed visualization of amyloid-angiopathy at capillary level, which is impossible to achieve with other approaches.XPCT emerges as added-value technology to explore AD mouse brain as a whole, preserving tissue chemistry and structure, enabling the comparison of physiological vs. pathological states at the level of crucial disease targets. In-vivo translation will permit to monitor emerging therapeutic approaches and possibly shed new light on pathological mechanisms of neurodegenerative diseases

Low oxygen tension primes aortic endothelial cells to the reparative effect of tissue-protective cytokines

Erythropoietin (EPO) has both erythropoietic and tissue-protective properties. The EPO analogues carbamylated EPO (CEPO) and pyroglutamate helix B surface peptide (pHBSP) lack the erythropoietic activity of EPO but retain the tissue-protective properties that are mediated by a heterocomplex of EPO receptor (EPOR) and the β common receptor (βCR). We studied the action of EPO and its analogues in a model of wound healing where a bovine aortic endothelial cells (BAECs) monolayer was scratched and the scratch closure was assessed over 24 h under different oxygen concentrations. We related the effects of EPO and its analogues on repair to their effect on BAECs proliferation and migration (evaluated using a micro-Boyden chamber). EPO, CEPO and pHBSP enhanced scratch closure only at lower oxygen (5%), while their effect at atmospheric oxygen (21%) was not significant. The mRNA expression of EPOR was doubled in 5% compared to 21% oxygen, and this was associated with increased EPOR assessed by immunofluorescence and Western blot. By contrast βCR mRNA levels were similar in 5% and 21% oxygen. EPO and its analogues increased both BAECs proliferation and migration, suggesting that both may be involved in the reparative process. The priming effect of low oxygen tension on the action of tissue-protective cytokines may be of relevance to vascular disease, including atherogenesis and restenosis

Exploiting endocytosis for transfection of mRNA for cytoplasmatic delivery using cationic gold nanoparticles

Gene therapy holds promise to cure various diseases at the fundamental level. For that, efficient carriers are needed for successful gene delivery. Synthetic 'non-viral' vectors, as cationic polymers, are quickly gaining popularity as efficient vectors for transmitting genes. However, they suffer from high toxicity associated with the permeation and poration of the cell membrane. This toxic aspect can be eliminated by nanoconjugation. Still, results suggest that optimising the oligonucleotide complexation, ultimately determined by the size and charge of the nanovector, is not the only barrier to efficient gene delivery. We herein develop a comprehensive nanovector catalogue comprising different sizes of Au NPs functionalized with two different cationic molecules and further loaded with mRNA for its delivery inside the cell. Tested nanovectors showed safe and sustained transfection efficiencies over 7 days, where 50 nm Au NPs displayed the highest transfection rates. Remarkably, protein expression was increased when nanovector transfection was performed combined with chloroquine. Cytotoxicity and risk assessment demonstrated that nanovectors are safe, ascribed to lesser cellular damage due to their internalization and delivery via endocytosis. Obtained results may pave the way to design advanced and efficient gene therapies for safely transferring oligonucleotides

Cardiac Transcription Factor Nkx2.5 Is Downregulated under Excessive O-GlcNAcylation Condition

Post-translational modification of proteins with O-linked N-acetylglucosamine (O-GlcNAc) is linked the development of diabetic cardiomyopathy. We investigated whether Nkx2.5 protein, a cardiac transcription factor, is regulated by O-GlcNAc. Recombinant Nkx2.5 (myc-Nkx2.5) proteins were reduced by treatment with the O-GlcNAcase inhibitors STZ and O-(2-acetamido-2-deoxy-D-glucopyroanosylidene)-amino-N-phenylcarbamate; PUGNAC) as well as the overexpression of recombinant O-GlcNAc transferase (OGT-flag). Co-immunoprecipitation analysis revealed that myc-Nkx2.5 and OGT-flag proteins interacted and myc-Nkx2.5 proteins were modified by O-GlcNAc. In addition, Nkx2.5 proteins were reduced in the heart tissue of streptozotocin (STZ)-induced diabetic mice and O-GlcNAc modification of Nkx2.5 protein increased in diabetic heart tissue compared with non-diabetic heart. Thus, excessive O-GlcNAcylation causes downregulation of Nkx2.5, which may be an underlying contributing factor for the development of diabetic cardiomyopathy

Duration of Untreated Cardiac Arrest and Clinical Relevance of Animal Experiments : The Relationship Between the “No-Flow” Duration and the Severity of Post-Cardiac Arrest Syndrome in a Porcine Model

INTRODUCTION: The study investigated the effect of untreated cardiac arrest (CA), i.e. \u201cno-flow\u201d time, on post-resuscitation myocardial and neurological injury, and survival in a pig model to identify an optimal duration that adequately reflects the most frequent clinical scenario. METHODS:: An established model of myocardial infarction followed by CA and cardiopulmonary resuscitation was used. Twenty-two pigs were subjected to 3 no-flow durations: short (8\u201310?min); intermediate (12\u201313?min); and long (14\u201315?min). Left ventricular ejection fraction (LVEF) was assessed together with thermodilution cardiac output (CO) and high sensitivity cardiac troponin T (hs-cTnT). Neurological impairment was evaluated by neurological scores, serum neuron specific enolase (NSE), and histopathology. RESULTS:: More than 60% of animals survived when the duration of CA was 6413?min, compared to only 20% for a duration 6514?min. Neuronal degeneration and neurological scores showed a trend towards a worse recovery for longer no-flow durations. No animals achieved a good neurological recovery for a no-flow 6514?min, in comparison to a 56% for a duration 6413?min (p?=?0.043). Serum NSE levels significantly correlated with the no-flow duration (r?=?0.892). Longer durations of CA were characterized by lower LVEF and CO compared to shorter durations (p?<?0.05). The longer was the no-flow time, the higher was the number of defibrillations delivered (p?=?0.043). The defibrillations delivered significantly correlated with LVEF and plasma hs-cTnT. CONCLUSIONS:: Longer no-flow durations caused greater post-resuscitation myocardial and neurological dysfunction and reduced survival. An untreated CA of 12\u201313?min may be an optimal choice for a clinically relevant model

Light-Promoted Hydrogenation of Carbon Dioxide¿An Overview

[EN] Hydrogenation of carbon dioxide is considered as a viable strategy to generate fuels while closing the carbon cycle (heavily disrupted by the abuse in the exploitation of fossil resources) and reducing greenhouse gas emissions. The process can be performed by heat-powered catalytic processes, albeit conversion and selectivity tend to be reduced at increasing temperatures owing to thermodynamic constraints. Recent investigations, as summarised in this overview, have proven that light activation is a distinct possibility for the promotion of CO2 hydrogenation to fuels. This effect is particularly beneficial in methanation processes, which can be enhanced under simulated solar irradiation using materials based on metallic nanoparticles as catalysts. The use of nickel, ruthenium and rhodium has led to substantial efficiencies. Light-promoted processes entail performances on a par with (or even superior to) those of thermally-induced, industrially-relevant, commercial technologies.The author thanks the Spanish Government (Ministerio de Economía y Competitividad, MINECO) for financial support via a project for young researchers (CTQ2015-74138-JIN), and the ‘‘Severo Ochoa’’ programme (SEV 2012-0267). The European Union is also acknowledged for the SynCatMatch project (ERCAdG-2014-671093)Puga Vaca, A. (2016). Light-Promoted Hydrogenation of Carbon Dioxide¿An Overview. Topics in Catalysis. 59(15-16):1268-1278. https://doi.org/10.1007/s11244-016-0658-zS126812785915-16Centi G, Perathoner S (2009) Opportunities and prospects in the chemical recycling of carbon dioxide to fuels. Catal Today 148:191–205Aresta M, Dibenedetto A, Angelini A (2014) Catalysis for the valorization of exhaust carbon: from CO2 to chemicals, materials, and fuels. technological use of CO2. Chem Rev 114:1709–1742Centi G, Quadrelli EA, Perathoner S (2013) Catalysis for CO2 conversion: a key technology for rapid introduction of renewable energy in the value chain of chemical industries. Energy Environ Sci 6:1711–1731Wang W, Wang S, Ma X, Gong J (2011) Recent advances in catalytic hydrogenation of carbon dioxide. Chem Soc Rev 40:3703–3727Gao J, Liu Q, Gu F, Liu B, Zhong Z, Su F (2015) Recent advances in methanation catalysts for the production of synthetic natural gas. RSC Adv 5:22759–22776Armaroli N, Balzani V (2011) The hydrogen issue. ChemSusChem 4:21–36Gao J, Wang Y, Ping Y, Hu D, Xu G, Gu F, Su F (2012) A thermodynamic analysis of methanation reactions of carbon oxides for the production of synthetic natural gas. RSC Adv 2:2358–2368Jadhav SG, Vaidya PD, Bhanage BM, Joshi JB (2014) Catalytic carbon dioxide hydrogenation to methanol: a review of recent studies. Chem Eng Res Des 92:2557–2567de Richter RK, Ming T, Caillol S (2013) Fighting global warming by photocatalytic reduction of CO2 using giant photocatalytic reactors. Renew Sust Energ Rev 19:82–106Schach M-O, Schneider R, Schramm H, Repke J-U (2010) Techno-economic analysis of postcombustion processes for the capture of carbon dioxide from power plant flue gas. Ind Eng Chem Res 49:2363–2370Centi G, Perathoner S (2010) Towards solar fuels from water and CO2. ChemSusChem 3:195–208Corma A, Garcia H (2013) Photocatalytic reduction of CO2 for fuel production: possibilities and challenges. J Catal 308:168–175Izumi Y (2013) Recent advances in the photocatalytic conversion of carbon dioxide to fuels with water and/or hydrogen using solar energy and beyond. Coord Chem Rev 257:171–186Dhakshinamoorthy A, Navalon S, Corma A, Garcia H (2012) Photocatalytic CO2 reduction by TiO2 and related titanium containing solids. Energy Environ Sci 5:9217–9233Indrakanti VP, Kubicki JD, Schobert HH (2009) Photoinduced activation of CO2 on Ti-based heterogeneous catalysts: current state, chemical physics-based insights and outlook. Energy Environ Sci 2:745–758Ozin GA (2015) You can’t have an energy revolution without transforming advances in materials, chemistry and catalysis into policy change and action. Energy Environ Sci 8:1682–1684Ozin GA (2015) Throwing new light on the reduction of CO2. Adv Mater 27:1957–1963Abe T, Tanizawa M, Watanabe K, Taguchi A (2009) CO2 methanation property of Ru nanoparticle-loaded TiO2 prepared by a polygonal barrel-sputtering method. Energy Environ Sci 2:315–321Li Y, Lu G, Ma J (2014) Highly active and stable nano NiO-MgO catalyst encapsulated by silica with a core-shell structure for CO2 methanation. RSC Adv 4:17420–17428Garbarino G, Bellotti D, Riani P, Magistri L, Busca G (2015) Methanation of carbon dioxide on Ru/Al2O3 and Ni/Al2O3 catalysts at atmospheric pressure: catalysts activation, behaviour and stability. Int J Hydrogen Energy 40:9171–9182Carenco S, Wu C-H, Shavorskiy A, Alayoglu S, Somorjai GA, Bluhm H, Salmeron M (2015) Synthesis and structural evolution of nickel-cobalt nanoparticles under H2 and CO2. Small 11:3045–3053Sharafutdinov I, Elkjaer CF, de Carvalho HWP, Gardini D, Chiarello GL, Damsgaard CD, Wagner JB, Grunwaldt J-D, Dahl S, Chorkendorff I (2014) Intermetallic compounds of Ni and Ga as catalysts for the synthesis of methanol. J Catal 320:77–88Studt F, Sharafutdinov I, Abild-Pedersen F, Elkjaer CF, Hummelshøj JS, Dahl S, Chorkendorff I, Nørskov JK (2014) Discovery of a Ni-Ga catalyst for carbon dioxide reduction to methanol. Nat Chem 6:320–324Garbarino G, Riani P, Magistri L, Busca G (2014) A study of the methanation of carbon dioxide on Ni/Al2O3 catalysts at atmospheric pressure. Int J Hydrogen Energy 39:11557–11565Iablokov V, Beaumont SK, Alayoglu S, Pushkarev VV, Specht C, Gao J, Alivisatos AP, Kruse N, Somorjai GA (2012) Size-controlled model CO nanoparticle catalysts for CO2 hydrogenation: synthesis, characterization, and catalytic reactions. Nano Lett 12:3091–3096Behrens M, Studt F, Kasatkin I, Kühl S, Hävecker M, Abild-Pedersen F, Zander S, Girgsdies F, Kurr P, Kniep B-L, Tovar M, Fischer RW, Nørskov JK, Schlögl R (2012) The active site of methanol synthesis over Cu/ZnO/Al2O3 industrial catalysts. Science 336:893–897Graciani J, Mudiyanselage K, Xu F, Baber AE, Evans J, Senanayake SD, Stacchiola DJ, Liu P, Hrbek J, Fernández Sanz J, Rodriguez JA (2014) Highly active copper-ceria and copper-ceria-titania catalysts for methanol synthesis from CO2. Science 345:546–550Fiordaliso EM, Sharafutdinov I, Carvalho HWP, Grunwaldt J-D, Hansen TW, Chorkendorff I, Wagner JB, Damsgaard CD (2015) Intermetallic GaPd2 nanoparticles on SiO2 for low-pressure CO2 hydrogenation to methanol: catalytic performance and in situ characterization. ACS Catal 5:5827–5836Kohno Y, Tanaka T, Funabiki T, Yoshida S (1997) Photoreduction of carbon dioxide with hydrogen over ZrO2. Chem Commun 9:841–842Kohno Y, Tanaka T, Funabiki T, Yoshida S (2000) Photoreduction of CO2 with H2 over ZrO2. A study of interaction of hydrogen with photoexcited CO2. Phys Chem Chem Phys 2:2635–2639Kohno Y, Ishikawa H, Tanaka T, Funabiki T, Yoshida S (2001) Photoreduction of carbon dioxide by hydrogen over magnesium oxide. Phys Chem Chem Phys 3:1108–1113Teramura K, Tsuneoka H, Shishido T, Tanaka T (2008) Effect of H2 gas as a reductant on photoreduction of CO2 over a Ga2O3 photocatalyst. Chem Phys Lett 467:191–194Tsuneoka H, Teramura K, Shishido T, Tanaka T (2010) Adsorbed Species of CO2 and H2 on Ga2O3 for the Photocatalytic Reduction of CO2. J Phys Chem C 114:8892–8898Teramura K, S-i Okuoka, Tsuneoka H, Shishido T, Tanaka T (2010) Photocatalytic reduction of CO2 using H2 as reductant over ATaO3 photocatalysts (A = Li, Na, K). Appl Catal B 96:565–568Kohno Y, Hayashi H, Takenaka S, Tanaka T, Funabiki T, Yoshida S (1999) Photo-enhanced reduction of carbon dioxide with hydrogen over Rh/TiO2. J Photochem Photobiol A 126:117–123Lo C-C, Hung C-H, Yuan C-S, Wu J-F (2007) Photoreduction of carbon dioxide with H2 and H2O over TiO2 and ZrO2 in a circulated photocatalytic reactor. Sol Energy Mater Sol Cells 91:1765–1774Hoch LB, Wood TE, O’Brien PG, Liao K, Reyes LM, Mims CA, Ozin GA (2014) The rational design of a single-component photocatalyst for gas-phase CO2 reduction using both UV and visible light. Adv Sci 1:1400013Li M, Li P, Chang K, Wang T, Liu L, Kang Q, Ouyang S, Ye J (2015) Highly efficient and stable photocatalytic reduction of CO2 to CH4 over Ru loaded NaTaO3. Chem Commun 51:7645–7648Tahir M, Amin NS (2015) Photocatalytic CO2 reduction with H2 as reductant over copper and indium co-doped TiO2 nanocatalysts in a monolith photoreactor. Appl Catal A 493:90–102Tahir M, Amin NS (2016) Performance analysis of nanostructured NiO–In2O3/TiO2 catalyst for CO2 photoreduction with H2 in a monolith photoreactor. Chem Eng J 285:635–649Ahmed N, Shibata Y, Taniguchi T, Izumi Y (2011) Photocatalytic conversion of carbon dioxide into methanol using zinc-copper-M(III) (M = aluminum, gallium) layered double hydroxides. J Catal 279:123–135Ahmed N, Morikawa M, Izumi Y (2012) Photocatalytic conversion of carbon dioxide into methanol using optimized layered double hydroxide catalysts. Catal Today 185:263–269Yang C-C, Vernimmen J, Meynen V, Cool P, Mul G (2011) Mechanistic study of hydrocarbon formation in photocatalytic CO2 reduction over Ti-SBA-15. J Catal 284:1–8Thampi KR, Kiwi J, Grätzel M (1987) Methanation and photo-methanation of carbon-dioxide at room-temperature and atmospheric pressure. Nature 327:506–508O’Brien PG, Sandhel A, Wood TE, Jelle AA, Hoch LB, Perovic DD, Mims CA, Ozin GA (2014) Photomethanation of gaseous CO2 over RU/silicon nanowire catalysts with visible and near-infrared photons. Adv Sci 1:1400001Meng X, Wang T, Liu L, Ouyang S, Li P, Hu H, Kako T, Iwai H, Tanaka A, Ye J (2014) Photothermal conversion of CO2 into CH4 with H2 over group VIII nanocatalysts: an alternative approach for solar fuel production. Angew Chem Int Ed 53:11478–11482Sastre F, Puga AV, Liu L, Corma A, García H (2014) Complete photocatalytic reduction of CO2 to methane by H2 under solar light irradiation. J Am Chem Soc 136:6798–6801Hong J, Zhang W, Ren J, Xu R (2013) Photocatalytic reduction of CO2: a brief review on product analysis and systematic methods. Anal Methods 5:1086–1097Yang C-C, Yu Y-H, van der Linden B, Wu JCS, Mul G (2010) Artificial photosynthesis over crystalline TiO2-based catalysts: fact or fiction. J Am Chem Soc 132:8398–8406Kohno Y, Tanaka T, Funabiki T, Yoshida S (1998) Identification and reactivity of a surface intermediate in the photoreduction of CO2 with H2 over ZrO2. J Chem Soc Faraday Trans 94:1875–1880Teramura K, Tanaka T, Ishikawa H, Kohno Y, Funabiki T (2004) Photocatalytic reduction of CO2 to CO in the presence of H2 or CH4 as a reductant over MgO. J Phys Chem B 108:346–354Zhang H, Wang T, Wang J, Liu H, Dao TD, Li M, Liu G, Meng X, Chang K, Shi L, Nagao T, Ye J (2016) Surface-plasmon-enhanced photodriven CO2 reduction catalyzed by metal-organic-framework-derived iron nanoparticles encapsulated by ultrathin carbon layers. Adv Mater 28:3703–3710Morikawa M, Ahmed N, Yoshida Y, Izumi Y (2014) Photoconversion of carbon dioxide in zinc-copper-gallium layered double hydroxides: the kinetics to hydrogen carbonate and further to CO/methanol. Appl Catal B 144:561–569Sabatier P (1910) Making methane or mixtures of methane and hydrogen, US Pat. 956734Melsheimer J, Guo W, Ziegler D, Wesemann M, Schlögl R (1991) Methanation of carbon dioxide over Ru/Titania at room temperature: explorations for a photoassisted catalytic reaction. Catal Lett 11:157–168Lin X, Yang K, Si R, Chen X, Dai W, Fu X (2014) Photoassisted catalytic methanation of CO in H2-rich stream over Ru/TiO2. Appl Catal B 147:585–591Lin X, Lin L, Huang K, Chen X, Dai W, Fu X (2015) CO methanation promoted by UV irradiation over Ni/TiO2. Appl Catal B 168–169:416–422Sastre F, Oteri M, Corma A, García H (2013) Photocatalytic water gas shift using visible or simulated solar light for the efficient, room-temperature hydrogen generation. Energy Environ Sci 6:2211–2215Sastre F, Corma A, García H (2013) Visible-light photocatalytic conversion of carbon monoxide to methane by nickel(ii) oxide. Angew Chem Int Ed 52:12983–12987Zhao Y, Zhao B, Liu J, Chen G, Gao R, Yao S, Li M, Zhang Q, Gu L, Xie J, Wen X, Wu L-Z, Tung C-H, Ma D, Zhang T (2016) Oxide-modified nickel photocatalyst for the production of hydrocarbons in visible light. Angew. Chem. Int. Ed. 55:4215–4219Albero J, Garcia H, Corma A (2016) Temperature dependence of solar light assisted CO2 reduction on Ni based photocatalyst. Top Catal 59:787–79

Effects of Post-Resuscitation Treatment with N-acetylcysteine on Cardiac Recovery in Hypoxic Newborn Piglets

AIMS: Although N-acetylcysteine (NAC) can decrease reactive oxygen species and improve myocardial recovery after ischemia/hypoxia in various acute animal models, little is known regarding its long-term effect in neonatal subjects. We investigated whether NAC provides prolonged protective effect on hemodynamics and oxidative stress using a surviving swine model of neonatal asphyxia. METHODS AND RESULTS: Newborn piglets were anesthetized and acutely instrumented for measurement of systemic hemodynamics and oxygen transport. Animals were block-randomized into a sham-operated group (without hypoxia-reoxygenation [H-R, n = 6]) and two H-R groups (2 h normocapnic alveolar hypoxia followed by 48 h reoxygenation, n = 8/group). All piglets were acidotic and in cardiogenic shock after hypoxia. At 5 min after reoxygenation, piglets were given either saline or NAC (intravenous 150 mg/kg bolus + 20 mg/kg/h infusion) via for 24 h in a blinded, randomized fashion. Both cardiac index and stroke volume of H-R controls remained lower than the pre-hypoxic values throughout recovery. Treating the piglets with NAC significantly improved cardiac index, stroke volume and systemic oxygen delivery to levels not different from those of sham-operated piglets. Accompanied with the hemodynamic improvement, NAC-treated piglets had significantly lower plasma cardiac troponin-I, myocardial lipid hydroperoxides, activated caspase-3 and lactate levels (vs. H-R controls). The change in cardiac index after H-R correlated with myocardial lipid hydroperoxides, caspase-3 and lactate levels (all p<0.05). CONCLUSIONS: Post-resuscitation administration of NAC reduces myocardial oxidative stress and caused a prolonged improvement in cardiac function and in newborn piglets with H-R insults